Super giant basal cell carcinoma in an autistic patient: A case report
- PMID: 32733678
- PMCID: PMC7370554
- DOI: 10.1177/2050313X20939481
Super giant basal cell carcinoma in an autistic patient: A case report
Abstract
Basal cell carcinoma is the most common skin cancer in the world and is generally treated when small in size with an excellent prognosis. Rarely, basal cell carcinoma will grow to be larger than 5 cm, at which point they are termed giant basal cell carcinoma. Giant basal cell carcinoma comprises only 0.5% of all basal cell carcinoma, but is associated with impaired quality of life and increased risk of metastasis. When a basal cell carcinoma grows to over 20 cm in size, it is termed super giant basal cell carcinoma. Here, we report a case of both a super-giant basal cell carcinoma and a giant basal cell carcinoma developing over 10-12 years on the upper back and anterior chest wall of an autistic male. Generally, this presentation is associated with neglect on the part of the patient. This case report demonstrates a super-giant basal cell carcinoma developing secondary to patient neglect in the context of comorbid mental illness.
Keywords: Super-giant basal cell carcinoma; Vismodegib; autism; cancer.
© The Author(s) 2020.
Conflict of interest statement
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Archontaki M, Stavrianos SD, Korkolis DP, et al. Giant basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res 2009; 29(7): 2655–2663. - PubMed
-
- Randle HW, Roenigk RK, Brodland DG. Giant basal cell carcinoma (T3): who is at risk? Cancer 1993; 72(5): 1624–1630. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
